More Business Wire
View Older Stories View Newer Stories-
PitchBook Wins 2025 TrustRadius Tech Cares Award
-
Amber Specialty Pharmacy Begins Dispensing Newly Approved BRINSUPRI™ (brensocatib) for Non-Cystic Fibrosisbronchiectasis (NCFB)
-
FCPT Announces Sale-Leaseback of Four Burger King Properties from Ampler Restaurant Group for $8.1 Million
-
Mobile Developers Now Get Greater Control of Their Revenue, Ownership of Their Data, and Direct-to-Consumer Capabilities With New Features for Xsolla’s Leading Web Shop
-
Great Quest Announces Extension of Final Tranche of Private Placement
-
Grupo Supervielle Reports 2Q25 Results
-
CUPE: Air Canada is missing in action at the bargaining table
-
Kontrol Technologies Announces Second Quarter 2025 Financial Results
-
Kemper Announces $150 Million Accelerated Share Repurchase
-
Cybin Reports Important Progress on Key Milestones and First Quarter Fiscal Year 2026 Financial Results
-
Halliburton Announces Dividend
-
Cresco Labs Closes $325 Million Senior Secured Term Loan Refinancing
-
FrontView REIT Announces Second Quarter 2025 Results and Updated Full Year 2025 Guidance
-
AM Best Affirms Credit Ratings of Sammons Financial Group, Inc. and Its Subsidiaries
-
The Democracy Center Presents “Breaking the Frame: Two Solo Shows on Art and Identity” From August 21–23
-
UN/COMMON Named to 2025 Inc. 5000 List, Celebrating a Decade of Growth & Client Success
-
Carlisle Companies Announces Pricing of Senior Notes Offering
-
UNIFI®, Makers of REPREVE®, Schedules Fourth Quarter Fiscal 2025 Earnings Conference Call
-
Afya Limited Announces a New Share Repurchase Program
-
Kimball Electronics Reports Q4 Results With Solid Finish to the Fiscal Year; Company Provides Guidance for Fiscal 2026
-
Logistic Properties of the Americas Announces Second Quarter 2025 Earnings Results
-
Adjournment of Special Meetings of Stockholders
-
Klaviyo Announces Launch of Proposed Secondary Offering of Series A Common Stock
-
The Estée Lauder Companies to Webcast Discussion of Fiscal 2025 Fourth Quarter and Full Year Results on August 20, 2025
-
City Ventures Announces Final Sales Release at Grove Village in Santa Rosa
-
ADM to Present at 2025 Barclays Annual Global Consumer Staples Conference
-
Empire Petroleum Reports Results for Second Quarter 2025 and Demonstrates Operational Momentum
-
Lantern Pharma Reports Second Quarter 2025 Financial Results and Business Updates
-
Dan Simkowitz to Speak at the Barclays Global Financial Services Conference
-
Adagio Medical Reports Second Quarter 2025 Results
-
Radian Declares Regular Quarterly Dividend
-
Layne, A Granite Company, to Construct Two High-Capacity Horizontal Collector Wells for Lewis and Clark Regional Water System
-
Pioneer Diversified High Income Fund, Inc. Announces Results of Special Meeting of Stockholders: Proposal to Liquidate and Dissolve the Fund is Approved
-
Cinemark Declares Quarterly Cash Dividend of $0.08
-
Verastem Oncology Announces Late-Breaking Abstract from Partner GenFleet Therapeutics’ Study in China of GFH375 (VS-7375) in Advanced Non-Small Cell Lung Cancer at IASLC 2025 World Conference on Lun
-
Luxfer Appoints Stewart Watson to Board of Directors
-
CI&T Reports 12.3% Organic Revenue Growth at Constant Currency in 2Q25 Results
-
Fidelis Insurance Group Reports 2025 Second Quarter Results
-
StandardAero Announces Second Quarter Results
-
Verde Clean Fuels, Inc. Reports Q2 2025 Results
-
Cheniere Highlights Success Through Teamwork in 2024 Corporate Responsibility Report
-
Global Medical REIT Inc. Announces the Approval of a $50 Million Common Stock Repurchase Program and One-for-Five Reverse Stock Split
-
IF Bancorp, Inc. Announces Cash Dividend
-
Monro, Inc. Declares Quarterly Cash Dividend
-
IFF to Webcast Fireside Chat at Barclays Global Consumer Staples Conference on Sept. 4
-
MetLife CEO Michel Khalaf and CFO John McCallion to Speak at the 2025 Keefe, Bruyette & Woods Insurance Conference
-
Boston Omaha Corporation Announces Second Quarter 2025 Financial Results
-
Franklin Covey Co. Announces Replenishment of Share Repurchase Program Up to $50 Million and Adoption of Rule 10b5-1 Trading Plan
-
Sarepta Therapeutics Announces Advancement of siRNA Collaboration and Sale of Arrowhead Equity Investment
-
Ibotta Reports Second Quarter 2025 Financial Results

